Germline mutations and somatic inactivation of TRIM28 in Wilms tumour

PLoS Genet. 2018 Jun 18;14(6):e1007399. doi: 10.1371/journal.pgen.1007399. eCollection 2018 Jun.

Abstract

Wilms tumour is a childhood tumour that arises as a consequence of somatic and rare germline mutations, the characterisation of which has refined our understanding of nephrogenesis and carcinogenesis. Here we report that germline loss of function mutations in TRIM28 predispose children to Wilms tumour. Loss of function of this transcriptional co-repressor, which has a role in nephrogenesis, has not previously been associated with cancer. Inactivation of TRIM28, either germline or somatic, occurred through inactivating mutations, loss of heterozygosity or epigenetic silencing. TRIM28-mutated tumours had a monomorphic epithelial histology that is uncommon for Wilms tumour. Critically, these tumours were negative for TRIM28 immunohistochemical staining whereas the epithelial component in normal tissue and other Wilms tumours stained positively. These data, together with a characteristic gene expression profile, suggest that inactivation of TRIM28 provides the molecular basis for defining a previously described subtype of Wilms tumour, that has early age of onset and excellent prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers, Tumor / genetics
  • Epigenesis, Genetic
  • Exome Sequencing
  • Female
  • Gene Expression Profiling
  • Germ-Line Mutation*
  • Humans
  • Kidney / pathology
  • Kidney Neoplasms / epidemiology
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / pathology
  • Loss of Function Mutation*
  • Male
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / genetics*
  • Neoplasm Recurrence, Local / pathology
  • Prognosis
  • Tripartite Motif-Containing Protein 28 / genetics*
  • Urothelium / pathology
  • Wilms Tumor / epidemiology
  • Wilms Tumor / genetics*
  • Wilms Tumor / pathology
  • Young Adult

Substances

  • Biomarkers, Tumor
  • TRIM28 protein, human
  • Tripartite Motif-Containing Protein 28

Grants and funding

We acknowledge funding from the Ministry of Business Innovation & Employment (PROP-32643-JSPS-UOO) (www.mbie.govt.nz) (IMM), The Japanese Society for the Promotion of Science (http://www.jsps.go.jp) (RF), The Tokyo Metropolitan Government (http://www.metro.tokyo.jp/) (RF), Cure Kids (www.curekids.org.nz) (BJH), the Dunedin School of Medicine (IMM), and the Maurice and Phyllis Paykel Trust (www.paykeltrust.co.nz) (IMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.